康众医疗
(688607)
| 流通市值：25.09亿 | | | 总市值：25.09亿 |
| 流通股本：8812.90万 | | | 总股本：8812.90万 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 144,883,131.24 | 58,438,952.04 | 298,100,384.74 | 195,501,808.26 |
| 营业收入 | 144,883,131.24 | 58,438,952.04 | 298,100,384.74 | 195,501,808.26 |
| 二、营业总成本 | 138,664,445.91 | 59,877,941.01 | 282,855,089.52 | 187,959,296.34 |
| 营业成本 | 88,525,970.48 | 37,465,870.05 | 180,262,672.32 | 111,618,458.75 |
| 税金及附加 | 661,273.22 | 332,700.05 | 1,868,850.97 | 1,541,365.32 |
| 销售费用 | 17,055,556.02 | 6,758,839.64 | 31,405,186.4 | 25,087,036.19 |
| 管理费用 | 16,855,697.52 | 9,095,008.83 | 26,779,469.45 | 18,711,493.31 |
| 研发费用 | 15,473,515.2 | 6,792,353.02 | 43,724,174.94 | 30,522,635.51 |
| 财务费用 | 92,433.47 | -566,830.58 | -1,185,264.56 | 478,307.26 |
| 其中:利息费用 | 298,318.76 | 292,031.56 | 752,045.28 | 754,092.88 |
| 其中:利息收入 | 367,355.12 | 155,123.24 | 1,071,859.32 | 438,095.71 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | -313,217 | -48,560.81 | -1,146,507.39 | -1,425,050.19 |
| 加:投资收益 | 821,072.79 | -654,012.06 | 6,940,131.05 | 7,899,779.41 |
| 资产处置收益 | 5,515.14 | 5,515.14 | -3,175.66 | - |
| 资产减值损失(新) | 85,757.17 | 18,900.4 | -5,329,912.79 | -1,178,675.91 |
| 信用减值损失(新) | -8,766,781.95 | -403,129.28 | -1,314,722.41 | -918,152.39 |
| 其他收益 | 1,292,029.48 | 569,191.79 | 3,185,095.44 | 2,185,374.03 |
| 四、营业利润 | -656,939.04 | -1,951,083.79 | 17,576,203.46 | 14,105,786.87 |
| 加:营业外收入 | 61,304.91 | 28,128.3 | 197,334.49 | 314,144.75 |
| 减:营业外支出 | 121,922.38 | - | 88,110.97 | 36,812.98 |
| 五、利润总额 | -717,556.51 | -1,922,955.49 | 17,685,426.98 | 14,383,118.64 |
| 减:所得税费用 | -38,731.7 | 1,390,122.33 | 9,718.95 | 1,791,208.95 |
| 六、净利润 | -678,824.81 | -3,313,077.82 | 17,675,708.03 | 12,591,909.69 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | -678,824.81 | -3,313,077.82 | 17,675,708.03 | 12,591,909.69 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | -739,398.63 | -3,281,292 | 17,652,732.43 | 12,586,307.98 |
| 少数股东损益 | 60,573.82 | -31,785.82 | 22,975.6 | 5,601.71 |
| 扣除非经常损益后的净利润 | -3,390,000.27 | -4,688,081.65 | 5,944,151.22 | 3,868,817.05 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | -0.01 | -0.04 | 0.2 | 0.14 |
| (二)稀释每股收益 | -0.01 | -0.04 | 0.2 | 0.14 |
| 八、其他综合收益 | 422,207.56 | 39,257.05 | 929,755.71 | -3,301,607.96 |
| 归属于母公司股东的其他综合收益 | 428,106.31 | 41,175.43 | 929,293.73 | -3,300,787.87 |
| 九、综合收益总额 | -256,617.25 | -3,269,984.01 | 18,605,463.74 | 9,291,941.91 |
| 归属于母公司股东的综合收益总额 | -311,292.32 | -3,240,116.57 | 18,582,026.16 | 9,285,520.11 |
| 归属于少数股东的综合收益总额 | 54,675.07 | -29,867.44 | 23,437.58 | 6,421.8 |
| 公告日期 | 2025-08-23 | 2025-04-26 | 2025-04-26 | 2024-10-26 |
| 审计意见(境内) | | | 标准无保留意见 | |